Biotech · Private company · Athens, GA, US
Nytricx Inc.
Track this companyFree. Adds Nytricx Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards6
- Engineering Nitric Oxide Releasing Intravascular Catheters with Solid Slippery Surfaces to Combat Infection and ThrombosisFiscal year 2026 · $314.3KNIH RePORTER 1R43HL184590-01 · fetched Nov 12, 2026
- Enhanced Prosthetic Vascular Graft Function by Local Release of Nitric OxideFiscal year 2024 · $311.8KNIH RePORTER 1R41HL176245-01 · fetched Nov 12, 2026
- Ultra-low Fouling and Anti-infective and Anti-thrombotic Nitric Oxide Releasing Intravascular CathetersFiscal year 2024 · $106.4KNIH RePORTER 3R42HL149595-02A1S1 · fetched Nov 12, 2026
- Ultra-low Fouling and Anti-infective and Anti-thrombotic Nitric Oxide Releasing Intravascular CathetersFiscal year 2024 · $50KNIH RePORTER 3R42HL149595-02A1S2 · fetched Nov 12, 2026
- Ultra-low Fouling and Anti-infective and Anti-thrombotic Nitric Oxide Releasing Intravascular CathetersFiscal year 2024 · $121.3KNIH RePORTER 3R42HL149595-03S1 · fetched Nov 12, 2026
- Ultra-low Fouling and Anti-infective and Anti-thrombotic Nitric Oxide Releasing Intravascular CathetersFiscal year 2024 · $875.9KNIH RePORTER 5R42HL149595-03 · fetched Nov 12, 2026